Literature DB >> 30171442

The effect of photobiomodulation on total amount of substance P in gingival crevicular fluid: placebo-controlled randomized clinical trial.

Ezgi Doğanay Yıldız1, Hakan Arslan2, Serhat Köseoğlu3, Taner Arabacı4, Dursun Anıl Yıldız4, Levent Savran5.   

Abstract

To investigate the effect of photobiomodulation (PBM) and placebo on total amount of substance P in gingival crevicular fluid (GCF) pre- and postoperatively. Twenty-six patients having tooth with symptomatic apical periodontitis were enrolled in this study. GCF was collected preoperatively. The patients were assigned into two groups (n = 13), as follows: placebo and PBM. Sampling was repeated 7 days after root canal treatment. Two independent samples T test was used for analyzing of the differences between preoperative and postoperative substance P levels in GCF (p = .05). The Pearson correlation analysis was used for determination of correlation among substance P levels and other variables. For placebo group, there is no significant difference between preoperative and postoperative total amounts of substance P level (p = 0.553). For PBM group, postoperative total amount of substance P level was significantly higher than those of preoperative level (p = 0.005). Within the limitation of the present study, PBM has immunomodulation effect linked to the modulation of the total amount of substance P in the gingival crevicular fluid. Thai Clinical Trials Registry: TCTR20161228002.

Entities:  

Keywords:  Gingival crevicular fluid; Photobiomodulation; Postoperative pain; Substance P

Mesh:

Substances:

Year:  2018        PMID: 30171442     DOI: 10.1007/s10103-018-2625-3

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  1 in total

1.  Effect of eye laterality on correction of myopic astigmatism with small incision lenticule extraction (SMILE) using vector analysis.

Authors:  Patricia Camille O Acosta; Reginald Robert G Tan; Irwin Y Cua; Stacey S Sau
Journal:  Int Ophthalmol       Date:  2022-02-14       Impact factor: 2.029

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.